Found 0 matching trials
Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients PHASE2 The ZANGEA trial is a open-label, single arm, multicenter phase II trial as...
Show More Learn More & Join Trial
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer PHASE3 This study is being done to answer the following questions: Is the chance o...
Show More Location
Cancer Center at Saint Joseph's
Learn More & Join Trial
Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer PHASE2 The purpose of this study is to evaluate the treatment of patients with loc...
Show More Status
Active Not Recruiting
Location
University of Rochester, James P. Wilmot Cancer Center
Learn More & Join Trial
PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors PHASE2 The primary objective of this study is to estimate the treatment effect on ...
Show More Learn More & Join Trial
Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus PHASE2 The purpose of this study is to learn how well a combination of iparomlimab...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Learn More & Join Trial
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) PHASE2 The purpose of this protocol is to allow continued treatment with conatumum...
Show More Learn More & Join Trial
Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer PHASE1 This is a Phase I, dose finding, multicentre study evaluating the maximal t...
Show More Location
Novarts Investigative Site
Learn More & Join Trial
Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer PHASE2 RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. D...
Show More Status
Active Not Recruiting
Location
Cancer Care Center at John Muir Health - Concord Campus
Learn More & Join Trial
A Study of Ramucirumab or Icrucumab in Colorectal Cancer PHASE2 The purpose of this study is to determine if participants with metastatic c...
Show More Location
ImClone Investigational Site
Learn More & Join Trial
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. PHASE1 The purpose of this study is to learn about the safety and effects of the s...
Show More Location
Highlands Oncology Group
Learn More & Join Trial